Compounded vs. brand-name semaglutide: what to know

As demand for GLP-1 drugs exploded, a parallel market grew alongside the brand-name products: compounded semaglutide, often sold through telehealth clinics and compounding pharmacies at a fraction of the brand price. For many people the appeal is obvious. The trade-offs are less obvious, and they are worth understanding before you decide.

What compounding actually is

Compounding is the practice of a pharmacy preparing a medication tailored to a patient, for example when someone needs a different dose or formulation than what is commercially available. It is legal and longstanding. During the GLP-1 shortages, federal rules allowed compounding pharmacies to make copies of drugs that were officially in short supply, which is how compounded semaglutide became widely available. The crucial distinction the FDA makes is that compounded drugs are not FDA-approved. The agency does not review them for safety, effectiveness, or quality the way it does brand-name products.

The case for compounded

The honest appeal is cost and access. Brand-name semaglutide carries a high list price, insurance coverage is inconsistent, and during shortages the brand products were simply hard to get. Compounded versions filled that gap at lower prices, often bundled into telehealth subscriptions. For people priced out of the brand entirely, it has been the only realistic path to treatment. Our guide to GLP-1 cost and insurance explains why the brand pricing is so painful in the first place.

The real risks

The trade-offs are not hypothetical. Because compounded products are not FDA-reviewed, you are relying entirely on the quality of the specific pharmacy. The FDA has warned about dosing errors with compounded semaglutide, including cases where patients measured the wrong dose from vials and overdosed. There have also been concerns about products using different salt forms of semaglutide (like semaglutide sodium or acetate) that were never studied for safety or effectiveness. Sourcing, sterility, and concentration consistency can vary between providers in ways you cannot easily verify. None of this means every compounded product is dangerous, but it means the safety net you assume with an approved drug is not there.

The shifting legal picture

This market is also unstable by design. Compounding of a drug copy is broadly permitted only while the brand is officially in shortage. As the FDA has signaled, once a drug comes off the shortage list, the legal basis for mass-compounding it largely disappears, and access can change quickly. People who built a plan around cheap compounded supply have been caught off guard by these transitions.

How to think about it

If you are considering compounded semaglutide, the questions that matter are: is the pharmacy reputable and state-licensed, is a real clinician overseeing your care and dosing, and do you understand that you are using a non-FDA-approved product. The same applies to the related trend of microdosing. The safest version of this is care directed by a licensed prescriber who can guide dosing, rather than self-administering from a vial without support.

Watch for the marketing red flags

The compounded market is also a marketing market, and some of the loudest claims are the least trustworthy. Be skeptical of any service that promises results without a real medical intake, that ships product based on a quick online quiz with no clinician contact, or that advertises proprietary blends mixing semaglutide with vitamins, B12, or other additives that were never studied together. Prices that look dramatically lower than everyone else can signal cut corners on sourcing or testing. A legitimate telehealth provider will require a genuine evaluation, will be transparent about which pharmacy fills the prescription, and will give you a way to reach a clinician when something goes wrong. If the experience feels more like buying a supplement than receiving care, that is a reason to slow down. It is also worth asking the simple question of what happens if the brand-name version comes back into full supply, because a service built entirely on compounding may have no clear plan to transition you to an approved product, and you could be left scrambling for continuity of care.

The takeaway

Compounded semaglutide can be a legitimate bridge for people priced out of the brand, but it trades regulatory oversight and consistency for affordability, and its legal footing can shift fast. If cost is the only thing standing between you and treatment, talk to a clinician about all your options, including manufacturer savings programs, before defaulting to a compounded product.

Related reading: Semaglutide vs. tirzepatide: how the two leading drugs compare.